Press Release September 3, 2019

Elanco to Buy Bayer’s Animal-Health Unit for $7.6 Billion

Alston & Bird acted as counsel to Credit Suisse, the financial advisor to Bayer AG, in the proposed sale by Bayer of its animal-health business to Elanco Animal Health Inc. in a cash and stock deal valued at $7.6 billion.

Alston & Bird consistently ranks among the top 10 law firms representing financial advisors in M&A as reported annually by Corporate Control Alert, the legal and financial dealmaking journal. In 2018, the firm acted as counsel to financial advisors in 19 deals with a total value of approximately $57 billion, earning it the No. 7 ranking among counsel to investment banks involving U.S. companies in deals valued at $100 million or more.

Advising Credit Suisse is Alston & Bird partner Stuart Rogers of the firm’s Financial Advisors Practice.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.